HLB Pep Co., Ltd. Logo

HLB Pep Co., Ltd.

Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.

196300 | KO

Overview

Corporate Details

ISIN(s):
KR7196300008
LEI:
Country:
South Korea
Address:
광주광역시 북구 첨단과기로 333 광주테크노파크 시험생산동 206호 , 광주광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pep Co., Ltd. is a biotechnology company that develops and produces therapeutic peptides and peptide-based biomaterials. The company's core activities include the manufacture and sale of Active Pharmaceutical Ingredients (APIs) from its GMP-certified facility, which was the first of its kind in Korea dedicated to peptide production. Its product and service portfolio consists of GMP and generic peptides, custom peptide synthesis for specific client requirements, and an extensive catalog of approximately 1,000 research peptides, including hormones, neuropeptides, and neurotoxins. HLB Pep focuses on research and development to discover new drug candidates, aiming to commercialize its innovations and expand its presence as a global biopharmaceutical firm.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Legal Proceedings Report
주요사항보고서(영업정지)
Korean 9.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 987.6 KB
2025-06-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 99.4 KB
2025-06-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-20 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-05-20 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.6 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 202.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 781.3 KB
2025-05-12 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.7 KB
2025-04-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 213.4 KB
2025-04-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.4 KB
2025-04-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 109.9 KB

Automate Your Workflow. Get a real-time feed of all HLB Pep Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Pep Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Pep Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea
355690
aTYR PHARMA INC Logo
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.
United States of America
AUPH
AURORA CANNABIS INC Logo
A global producer and seller of medical and recreational cannabis and derivative products.
United States of America
ACB
Autolus Therapeutics plc Logo
Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
AUTL
AVADEL PHARMACEUTICALS PLC Logo
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
United States of America
AVDL
Avidity Biosciences, Inc. Logo
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
United States of America
RNA
Axsome Therapeutics, Inc. Logo
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.
United States of America
AYTU

Talk to a Data Expert

Have a question? We'll get back to you promptly.